Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge

Infect Control Hosp Epidemiol. 2021 Jan;42(1):84-88. doi: 10.1017/ice.2020.368. Epub 2020 Jul 24.

Abstract

We observed bacterial or fungal coinfections in COVID-19 patients admitted between March 1 and April 18, 2020 (152 of 4,267, 3.6%). Among these patients, mortality was 57%; 74% were intubated; 51% with bacteremia had central venous catheters. Time to culture positivity was 6-7 days, and 79% had received prior antibiotics. Metallo-β-lactamase-producing E. cloacae coinfections occurred in 5 patients.

Publication types

  • Observational Study

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacteremia* / diagnosis
  • Bacteremia* / epidemiology
  • Bacteremia* / therapy
  • COVID-19* / epidemiology
  • COVID-19* / microbiology
  • COVID-19* / therapy
  • Central Venous Catheters / microbiology
  • Central Venous Catheters / statistics & numerical data
  • Coinfection* / epidemiology
  • Coinfection* / microbiology
  • Coinfection* / virology
  • Drug Resistance, Bacterial
  • Female
  • Humans
  • Male
  • Microbiological Techniques / methods
  • Microbiological Techniques / statistics & numerical data
  • Middle Aged
  • Mycoses* / diagnosis
  • Mycoses* / epidemiology
  • Mycoses* / therapy
  • New York / epidemiology
  • Outcome and Process Assessment, Health Care
  • Respiration, Artificial / statistics & numerical data
  • SARS-CoV-2 / isolation & purification*
  • Severity of Illness Index

Substances

  • Anti-Bacterial Agents